logo
Book a meeting
Kypha

Kypha

Medical Devices, 4320 FRST Park Ave, St Louis, Missouri, 63108, United States, 11-50 Employees

kypha.net

  • twitter
  • LinkedIn

phone no Phone Number: +13*********

Who is KYPHA

Kypha discovers, develops and commercializes innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. These tests have application across a wide range ...

Read More

lock icon Get Full Access
map
  • 4320 FRST Park Ave, St Louis, Missouri, 63108, United States Headquarters: 4320 FRST Park Ave, St Louis, Missouri, 63108, United States
  • 2009 Date Founded: 2009
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from KYPHA

Kypha Org Chart and Mapping

Employees
Gloria Loncharich

Gloria Loncharich

Director, Human Resources

Michelle Elvington

Michelle Elvington

Scientific Director- Complement and Clinical Development

Michelle Elvington

Michelle Elvington

Director, Research & Product Development

Martin Schmidt

Martin Schmidt

Chief Scientific Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for Kypha
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Kypha

Answer: Kypha's headquarters are located at 4320 FRST Park Ave, St Louis, Missouri, 63108, United States

Answer: Kypha's phone number is +13*********

Answer: Kypha's official website is https://kypha.net

Answer: Kypha's revenue is $10 Million to $25 Million

Answer: Kypha's SIC: 2834

Answer: Kypha has 11-50 employees

Answer: Kypha is in Medical Devices

Answer: Kypha contact info: Phone number: +13********* Website: https://kypha.net

Answer: Kypha discovers, develops and commercializes innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. These tests have application across a wide range of indications that include: lupus, stroke, traumatic brain injury, preeclampsia, infection, nephrology/kidney disease and transplant rejection. Potential implications include detecting the onset of adverse events earlier and optimizing treatment sooner, predicting outcomes more accurately, and managing disease and patient more effectively. Based on the ability to measure complement activation within the body, the company has developed a point of care platform called COMP ACT that delivers real time results to the physicians. Kypha has developed an extensive clinical collaborator network to support the clinical trials as well as the identification of new biomarkers across multiple indications.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access